Biosimilars in India; current status and future perspectives
Many key biologics are scheduled to lose their patent by the year 2020, which will provide the opportunity to other biopharmaceutical companies to develop the similar biologics. Biosimilar or similar biologic used has increased in the recent year following the approval of the first biosimilar in ear...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_b43038cbbb4a41a29b9d1e5c5196c58a | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Bikash R Meher |e author |
| 700 | 1 | 0 | |a Sakthi Balan |e author |
| 700 | 1 | 0 | |a Rashmi R Mohanty |e author |
| 700 | 1 | 0 | |a Monalisa Jena |e author |
| 700 | 1 | 0 | |a Smita Das |e author |
| 245 | 0 | 0 | |a Biosimilars in India; current status and future perspectives |
| 260 | |b Wolters Kluwer Medknow Publications, |c 2019-01-01T00:00:00Z. | ||
| 500 | |a 0975-7406 | ||
| 500 | |a 10.4103/JPBS.JPBS_167_18 | ||
| 520 | |a Many key biologics are scheduled to lose their patent by the year 2020, which will provide the opportunity to other biopharmaceutical companies to develop the similar biologics. Biosimilar or similar biologic used has increased in the recent year following the approval of the first biosimilar in early 2000. India is one of the leading manufacturers of similar biologics. India has developed a new guideline in 2012 for the pre- and post-marketing approval of similar biologics. | ||
| 546 | |a EN | ||
| 690 | |a Biosimilars | ||
| 690 | |a European Medicines Agency | ||
| 690 | |a Food and Drug Administration | ||
| 690 | |a similar biologics | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 690 | |a Analytical chemistry | ||
| 690 | |a QD71-142 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Pharmacy and Bioallied Sciences, Vol 11, Iss 1, Pp 12-15 (2019) | |
| 787 | 0 | |n http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2019;volume=11;issue=1;spage=12;epage=15;aulast=Meher | |
| 787 | 0 | |n https://doaj.org/toc/0975-7406 | |
| 856 | 4 | 1 | |u https://doaj.org/article/b43038cbbb4a41a29b9d1e5c5196c58a |z Connect to this object online. |